A sesquiterpene compound in ilex hainanensis and an extraction and separation method and application thereof
Lactones F, G, and H, which were not previously reported in the literature, were separated from *Tea japonica* by water decoction and column chromatography. This method fills the gap in the application of these compounds in antifungal infections, anti-inflammatory analgesia, antitumor drugs, and skin damage repair cosmetics, and enables the separation and efficacy verification of new compounds.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- GUANGZHOU BAIYUNSHAN JINGXIUTANG PHARM CO LTD
- Filing Date
- 2025-01-22
- Publication Date
- 2026-06-09
AI Technical Summary
There are no reports in the prior art regarding the use of quinquefoliolide FH and its application in the preparation of antifungal drugs, anti-inflammatory and analgesic drugs, antitumor drugs, and skin damage repair cosmetics.
Nine-section tea was extracted by water decoction, and purified by normal-phase silica gel column chromatography and C18 reversed-phase chromatography to separate nine-section tea lactone F, nine-section tea lactone G and nine-section tea lactone H. The lactones were then purified by gradient elution and purification using solvent systems with different ratios.
Three novel compounds previously unreported in the literature were successfully isolated and identified, exhibiting antibacterial and anti-inflammatory activities. They have potential development value for diseases such as fungal infections, pharyngitis, and pneumonia, and also possess skin damage repair and anti-aging effects, making them suitable for use in the cosmetics field.
Smart Images

Figure CN119912471B_ABST